{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:44:02Z","timestamp":1790844242403,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-021-00216-6","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T12:06:50Z","timestamp":1625141210000},"page":"853-864","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"2","author":[{"given":"Junyan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Cannizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Meier-Abt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Scheinost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9992-3109","authenticated-orcid":false,"given":"Peter-Martin","family":"Bruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9295-587X","authenticated-orcid":false,"given":"Holly A. R.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1104-727X","authenticated-orcid":false,"given":"Almut","family":"L\u00fctge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"H\u00fcllein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Giacopelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-9440","authenticated-orcid":false,"given":"Ferran","family":"Nadeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-9793","authenticated-orcid":false,"given":"El\u00edas","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Mangolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7247-311X","authenticated-orcid":false,"given":"Ingo","family":"Ringshausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2911-8830","authenticated-orcid":false,"given":"Martin","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-6660","authenticated-orcid":false,"given":"Dimitrios","family":"Mougiakakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6325-7861","authenticated-orcid":false,"given":"Bernd","family":"Bodenmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-1832","authenticated-orcid":false,"given":"Sascha","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7890-9845","authenticated-orcid":false,"given":"Thorsten","family":"Zenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0474-2218","authenticated-orcid":false,"given":"Wolfgang","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"216_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1182\/blood-2015-02-585042","volume":"126","author":"R Gui\u00e8ze","year":"2015","unstructured":"Gui\u00e8ze, R. & Wu, C. J. Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia. Blood 126, 445\u2013453 (2015).","journal-title":"Blood"},{"key":"216_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrc2764","volume":"10","author":"T Zenz","year":"2010","unstructured":"Zenz, T., Mertens, D., K\u00fcppers, R., D\u00f6hner, H. & Stilgenbauer, S. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat. Rev. Cancer 10, 37\u201350 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"216_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ng.3488","volume":"48","author":"CC Oakes","year":"2016","unstructured":"Oakes, C. C. et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat. Genet. 48, 253\u2013264 (2016).","journal-title":"Nat. Genet."},{"key":"216_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/leu.2014.252","volume":"29","author":"AC Queir\u00f3s","year":"2015","unstructured":"Queir\u00f3s, A. C. et al. A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact. Leukemia 29, 598\u2013605 (2015).","journal-title":"Leukemia"},{"key":"216_CR5","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle, R. N. et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94, 1840\u20131847 (1999).","journal-title":"Blood"},{"key":"216_CR6","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G. & Stevenson, F. K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94, 1848\u20131854 (1999).","journal-title":"Blood"},{"key":"216_CR7","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1182\/blood.2019000490","volume":"134","author":"B Giacopelli","year":"2019","unstructured":"Giacopelli, B. et al. Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia. Blood 134, 688\u2013698 (2019).","journal-title":"Blood"},{"key":"216_CR8","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1182\/blood-2011-06-338855","volume":"118","author":"FK Stevenson","year":"2011","unstructured":"Stevenson, F. K., Krysov, S., Davies, A. J., Steele, A. J. & Packham, G. B-cell receptor signaling in chronic lymphocytic leukemia. Blood 118, 4313\u20134320 (2011).","journal-title":"Blood"},{"key":"216_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1101\/gr.152132.112","volume":"24","author":"PG Ferreira","year":"2014","unstructured":"Ferreira, P. G. et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res. 24, 212\u2013226 (2014).","journal-title":"Genome Res."},{"key":"216_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1172\/JCI93801","volume":"128","author":"S Dietrich","year":"2018","unstructured":"Dietrich, S. et al. Drug-perturbation-based stratification of blood cancer. J. Clin. Invest. 128, 427\u2013445 (2018).","journal-title":"J. Clin. Invest."},{"key":"216_CR11","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3324\/haematol.2018.203067","volume":"104","author":"J Lu","year":"2019","unstructured":"Lu, J. et al. Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity. Haematologica 104, 1830\u20131840 (2019).","journal-title":"Haematologica"},{"key":"216_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/10428194.2018.1498494","volume":"60","author":"HD Popp","year":"2019","unstructured":"Popp, H. D. et al. Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. Leuk. Lymphoma 60, 795\u2013804 (2019).","journal-title":"Leuk. Lymphoma"},{"key":"216_CR13","doi-asserted-by":"publisher","first-page":"e8339","DOI":"10.15252\/msb.20188339","volume":"15","author":"J-P Mallm","year":"2019","unstructured":"Mallm, J.-P. et al. Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks. Mol. Syst. Biol. 15, e8339 (2019).","journal-title":"Mol. Syst. Biol."},{"key":"216_CR14","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1182\/blood-2013-02-427641","volume":"121","author":"Y Wan","year":"2013","unstructured":"Wan, Y. & Wu, C. J. SF3B1 mutations in chronic lymphocytic leukemia. Blood 121, 4627\u20134634 (2013).","journal-title":"Blood"},{"key":"216_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"475","author":"XS Puente","year":"2011","unstructured":"Puente, X. S. et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101\u2013105 (2011).","journal-title":"Nature"},{"key":"216_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature15395","volume":"526","author":"DA Landau","year":"2015","unstructured":"Landau, D. A. et al. Mutations driving CLL and their evolution in progression and relapse. Nature 526, 525\u2013530 (2015).","journal-title":"Nature"},{"key":"216_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","volume":"119","author":"D Rossi","year":"2012","unstructured":"Rossi, D. et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 119, 521\u2013529 (2012).","journal-title":"Blood"},{"key":"216_CR18","doi-asserted-by":"publisher","first-page":"e8124","DOI":"10.15252\/msb.20178124","volume":"14","author":"R Argelaguet","year":"2018","unstructured":"Argelaguet, R. et al. Multi-omics factor analysis: a framework for unsupervised integration of multi-omics data sets. Mol. Syst. Biol. 14, e8124 (2018).","journal-title":"Mol. Syst. Biol."},{"key":"216_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-124","volume":"11","author":"V Quesada","year":"2013","unstructured":"Quesada, V. et al. The genomic landscape of chronic lymphocytic leukemia: clinical implications. BMC Med. 11, 124 (2013).","journal-title":"BMC Med."},{"key":"216_CR20","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/leu.2011.125","volume":"25","author":"T Herold","year":"2011","unstructured":"Herold, T. et al. An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia. Leukemia 25, 1639\u20131645 (2011).","journal-title":"Leukemia"},{"key":"216_CR21","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1182\/blood-2012-03-416461","volume":"120","author":"H-Y Chuang","year":"2012","unstructured":"Chuang, H.-Y. et al. Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression. Blood 120, 2639\u20132649 (2012).","journal-title":"Blood"},{"key":"216_CR22","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.1158\/1078-0432.CCR-09-1132","volume":"15","author":"DR Friedman","year":"2009","unstructured":"Friedman, D. R. et al. A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia. Clin. Cancer Res. 15, 6947\u20136955 (2009).","journal-title":"Clin. Cancer Res."},{"key":"216_CR23","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3324\/haematol.2018.187583","volume":"103","author":"E Campo","year":"2018","unstructured":"Campo, E. et al. TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics. Haematologica 103, 1956\u20131968 (2018).","journal-title":"Haematologica"},{"key":"216_CR24","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","volume":"365","author":"L Wang","year":"2011","unstructured":"Wang, L. et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med. 365, 2497\u20132506 (2011).","journal-title":"N. Engl. J. Med."},{"key":"216_CR25","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1200\/JCO.2009.27.8762","volume":"28","author":"T Zenz","year":"2010","unstructured":"Zenz, T. et al. TP53 mutation and survival in chronic lymphocytic leukemia. J. Clin. Oncol. 28, 4473\u20134479 (2010).","journal-title":"J. Clin. Oncol."},{"key":"216_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4161\/epi.6.2.13528","volume":"6","author":"S Fabris","year":"2011","unstructured":"Fabris, S. et al. Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. Epigenetics 6, 188\u2013194 (2011).","journal-title":"Epigenetics"},{"key":"216_CR27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.2443","volume":"44","author":"M Kulis","year":"2012","unstructured":"Kulis, M. et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat. Genet. 44, 1236\u20131242 (2012).","journal-title":"Nat. Genet."},{"key":"216_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41588-018-0073-4","volume":"50","author":"W Zhou","year":"2018","unstructured":"Zhou, W. et al. DNA methylation loss in late-replicating domains is linked to mitotic cell division. Nat. Genet. 50, 591\u2013602 (2018).","journal-title":"Nat. Genet."},{"key":"216_CR29","doi-asserted-by":"publisher","unstructured":"Duran-Ferrer, M. et al. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome. Nat. Cancer https:\/\/doi.org\/10.1038\/s43018-020-00131-2 (2020).","DOI":"10.1038\/s43018-020-00131-2"},{"key":"216_CR30","doi-asserted-by":"publisher","first-page":"e1003994","DOI":"10.1371\/journal.pgen.1003994","volume":"9","author":"A Feldmann","year":"2013","unstructured":"Feldmann, A. et al. Transcription factor occupancy can mediate active turnover of DNA methylation at regulatory regions. PLoS Genet. 9, e1003994 (2013).","journal-title":"PLoS Genet."},{"key":"216_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature10716","volume":"480","author":"MB Stadler","year":"2011","unstructured":"Stadler, M. B. et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480, 490\u2013495 (2011).","journal-title":"Nature"},{"key":"216_CR32","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"216_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1182\/blood-2011-07-370403","volume":"119","author":"S Krysov","year":"2012","unstructured":"Krysov, S. et al. Surface IgM stimulation induces MEK1\/2-dependent MYC expression in chronic lymphocytic leukemia cells. Blood 119, 170\u2013179 (2012).","journal-title":"Blood"},{"key":"216_CR34","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.ccell.2018.11.001","volume":"34","author":"CJ Ott","year":"2018","unstructured":"Ott, C. J. et al. Enhancer architecture and essential core regulatory circuitry of chronic lymphocytic leukemia. Cancer Cell 34, 982\u2013995 (2018).","journal-title":"Cancer Cell"},{"key":"216_CR35","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1182\/blood.V95.3.999.003k10_999_1006","volume":"95","author":"T Decker","year":"2000","unstructured":"Decker, T. et al. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Blood 95, 999\u20131006 (2000).","journal-title":"Blood"},{"key":"216_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.leu.2402389","volume":"16","author":"T Decker","year":"2002","unstructured":"Decker, T. et al. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Leukemia 16, 327\u2013334 (2002).","journal-title":"Leukemia"},{"key":"216_CR37","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1158\/2159-8290.CD-17-0902","volume":"8","author":"HG Ozer","year":"2018","unstructured":"Ozer, H. G. et al. BRD4 profiling identifies critical chronic lymphocytic leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor. Cancer Discov. 8, 458\u2013477 (2018).","journal-title":"Cancer Discov."},{"key":"216_CR38","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.leukres.2009.12.020","volume":"34","author":"M Tarnani","year":"2010","unstructured":"Tarnani, M. et al. The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia. Leuk. Res. 34, 1189\u20131194 (2010).","journal-title":"Leuk. Res."},{"key":"216_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"216_CR40","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gks461","volume":"40","author":"D Wu","year":"2012","unstructured":"Wu, D. & Smyth, G. K. CAMERA: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res. 40, e133 (2012).","journal-title":"Nucleic Acids Res."},{"key":"216_CR41","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1182\/blood-2012-11-467670","volume":"122","author":"MF Pascutti","year":"2013","unstructured":"Pascutti, M. F. et al. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells. Blood 122, 3010\u20133019 (2013).","journal-title":"Blood"},{"key":"216_CR42","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1073\/pnas.1211130110","volume":"110","author":"L Vallat","year":"2013","unstructured":"Vallat, L. et al. Reverse-engineering the genetic circuitry of a cancer cell with predicted intervention in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 110, 459\u2013464 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"216_CR43","doi-asserted-by":"publisher","first-page":"17834","DOI":"10.1073\/pnas.0604129103","volume":"103","author":"KI Zeller","year":"2006","unstructured":"Zeller, K. I. et al. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl Acad. Sci. USA 103, 17834\u201317839 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"216_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/labinvest.2017.125","volume":"98","author":"PV Attwood","year":"2018","unstructured":"Attwood, P. V. & Muimo, R. The actions of NME1\/NDPK-A and NME2\/NDPK-B as protein kinases. Lab. Invest. 98, 283\u2013290 (2018).","journal-title":"Lab. Invest."},{"key":"216_CR45","doi-asserted-by":"publisher","first-page":"9021","DOI":"10.1093\/nar\/gks617","volume":"40","author":"M Swarnalatha","year":"2012","unstructured":"Swarnalatha, M., Singh, A. K. & Kumar, V. The epigenetic control of E-box and Myc-dependent chromatin modifications regulate the licensing of lamin B2 origin during cell cycle. Nucleic Acids Res. 40, 9021\u20139035 (2012).","journal-title":"Nucleic Acids Res."},{"key":"216_CR46","doi-asserted-by":"publisher","first-page":"100776","DOI":"10.1016\/j.tranon.2020.100776","volume":"13","author":"S Agarwal","year":"2020","unstructured":"Agarwal, S. et al. PAICS, a de novo purine biosynthetic enzyme, is overexpressed in pancreatic cancer and is involved in its progression. Transl. Oncol. 13, 100776 (2020).","journal-title":"Transl. Oncol."},{"key":"216_CR47","doi-asserted-by":"publisher","first-page":"17698","DOI":"10.18632\/oncotarget.4131","volume":"6","author":"M-M Coud\u00e9","year":"2015","unstructured":"Coud\u00e9, M.-M. et al. BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells. Oncotarget 6, 17698\u201317712 (2015).","journal-title":"Oncotarget"},{"key":"216_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/ijc.30412","volume":"140","author":"R V\u00e1zquez","year":"2017","unstructured":"V\u00e1zquez, R. et al. Promising in vivo efficacy of the BET bromodomain inhibitor OTX015\/MK-8628 in malignant pleural mesothelioma xenografts. Int. J. Cancer 140, 197\u2013207 (2017).","journal-title":"Int. J. Cancer"},{"key":"216_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.isci.2018.07.005","volume":"5","author":"LR Waters","year":"2018","unstructured":"Waters, L. R., Ahsan, F. M., Wolf, D. M., Shirihai, O. & Teitell, M. A. Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling. iScience 5, 99\u2013109 (2018).","journal-title":"iScience"},{"key":"216_CR50","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath, S. et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 49, D1541\u2013D1547 (2021).","journal-title":"Nucleic Acids Res."},{"key":"216_CR51","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","volume":"18","author":"M Morita","year":"2013","unstructured":"Morita, M. et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab. 18, 698\u2013711 (2013).","journal-title":"Cell Metab."},{"key":"216_CR52","doi-asserted-by":"publisher","first-page":"a014225","DOI":"10.1101\/cshperspect.a014225","volume":"4","author":"F Morrish","year":"2014","unstructured":"Morrish, F. & Hockenbery, D. MYC and mitochondrial biogenesis. Cold Spring Harb. Perspect. Med. 4, a014225 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"216_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.omtn.2019.05.003","volume":"17","author":"T Arif","year":"2019","unstructured":"Arif, T., Amsalem, Z. & Shoshan-Barmatz, V. Metabolic reprograming via silencing of mitochondrial VDAC1 expression encourages differentiation of cancer cells. Mol. Ther. Nucleic Acids 17, 24\u201337 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"216_CR54","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1016\/j.febslet.2008.11.004","volume":"582","author":"Y-P Tsai","year":"2008","unstructured":"Tsai, Y.-P., Teng, S.-C. & Wu, K.-J. Direct regulation of HSP60 expression by c-MYC induces transformation. FEBS Lett. 582, 4083\u20134088 (2008).","journal-title":"FEBS Lett."},{"key":"216_CR55","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrrheum.2011.110","volume":"7","author":"RK Cheung","year":"2011","unstructured":"Cheung, R. K. & Utz, P. J. Screening: CyTOF-the next generation of cell detection. Nat. Rev. Rheumatol. 7, 502\u2013503 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"216_CR56","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.4161\/cc.11.5.19518","volume":"11","author":"GP Mognol","year":"2012","unstructured":"Mognol, G. P., de Araujo-Souza, P. S., Robbs, B. K., Teixeira, L. K. & Viola, J. P. B. Transcriptional regulation of the c-Myc promoter by NFAT1 involves negative and positive NFAT-responsive elements. Cell Cycle 11, 1014\u20131028 (2012).","journal-title":"Cell Cycle"},{"key":"216_CR57","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/ijc.31057","volume":"142","author":"C Wolf","year":"2018","unstructured":"Wolf, C. et al. NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib. Int. J. Cancer 142, 322\u2013333 (2018).","journal-title":"Int. J. Cancer"},{"key":"216_CR58","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1172\/JCI23409","volume":"115","author":"BT Messmer","year":"2005","unstructured":"Messmer, B. T. et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J. Clin. Invest. 115, 755\u2013764 (2005).","journal-title":"J. Clin. Invest."},{"key":"216_CR59","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3324\/haematol.2010.022277","volume":"95","author":"E Gin\u00e9","year":"2010","unstructured":"Gin\u00e9, E. et al. Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (\u2018accelerated\u2019 chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica 95, 1526\u20131533 (2010).","journal-title":"Haematologica"},{"key":"216_CR60","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/14737159.2019.1623672","volume":"19","author":"JM Eastel","year":"2019","unstructured":"Eastel, J. M. et al. Application of NanoString technologies in companion diagnostic development. Expert Rev. Mol. Diagn. 19, 591\u2013598 (2019).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"216_CR61","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1074\/mcp.TIR119.001431","volume":"18","author":"S Amon","year":"2019","unstructured":"Amon, S. et al. Sensitive quantitative proteomics of human hematopoietic stem and progenitor cells by data-independent acquisition mass spectrometry. Mol. Cell Proteomics 18, 1454\u20131467 (2019).","journal-title":"Mol. Cell Proteomics"},{"key":"216_CR62","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nprot.2017.147","volume":"13","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Proteome-wide identification of ubiquitin interactions using UbIA-MS. Nat. Protoc. 13, 530\u2013550 (2018).","journal-title":"Nat. Protoc."},{"key":"216_CR63","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/bioinformatics\/18.suppl_1.S96","volume":"18","author":"W Huber","year":"2002","unstructured":"Huber, W., von Heydebreck, A., S\u00fcltmann, H., Poustka, A. & Vingron, M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18, S96\u2013S104 (2002).","journal-title":"Bioinformatics"},{"key":"216_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"216_CR65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. B"},{"key":"216_CR66","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"216_CR67","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"216_CR68","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.12688\/f1000research.8839.2","volume":"5","author":"J Maksimovic","year":"2016","unstructured":"Maksimovic, J., Phipson, B. & Oshlack, A. A cross-package Bioconductor workflow for analysing methylation array data. Version 3; peer review: 4 approved. F1000Res. 5, 1281 (2016).","journal-title":"F1000Res."},{"key":"216_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"key":"216_CR70","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.stem.2015.01.015","volume":"16","author":"ER Zunder","year":"2015","unstructured":"Zunder, E. R., Lujan, E., Goltsev, Y., Wernig, M. & Nolan, G. P. A continuous molecular roadmap to iPSC reprogramming through progression analysis of single-cell mass cytometry. Cell Stem Cell 16, 323\u2013337 (2015).","journal-title":"Cell Stem Cell"},{"key":"216_CR71","first-page":"95","volume":"377","author":"N Zivanovic","year":"2014","unstructured":"Zivanovic, N., Jacobs, A. & Bodenmiller, B. A practical guide to multiplexed mass cytometry. Curr. Top. Microbiol. Immunol. 377, 95\u2013109 (2014).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"216_CR72","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/cyto.a.22573","volume":"85","author":"GK Behbehani","year":"2014","unstructured":"Behbehani, G. K. et al. Transient partial permeabilization with saponin enables cellular barcoding prior to surface marker staining. Cytometry A 85, 1011\u20131019 (2014).","journal-title":"Cytometry A"},{"key":"216_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1006-0","volume":"17","author":"R Catena","year":"2016","unstructured":"Catena, R., \u00d6zcan, A., Jacobs, A., Chevrier, S. & Bodenmiller, B. AirLab: a cloud-based platform to manage and share antibody-based single-cell research. Genome Biol. 17, 142 (2016).","journal-title":"Genome Biol."},{"key":"216_CR74","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.12688\/f1000research.26073.1","volume":"9","author":"HL Crowell","year":"2020","unstructured":"Crowell, H. L. et al. An R-based reproducible and user-friendly preprocessing pipeline for CyTOF data. F1000Res. 9, 1263 (2020).","journal-title":"F1000Res."},{"key":"216_CR75","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cels.2018.02.010","volume":"6","author":"S Chevrier","year":"2018","unstructured":"Chevrier, S. et al. Compensation of signal spillover in suspension and imaging mass cytometry. Cell Syst. 6, 612\u2013620 (2018).","journal-title":"Cell Syst."},{"key":"216_CR76","doi-asserted-by":"publisher","first-page":"e1003806","DOI":"10.1371\/journal.pcbi.1003806","volume":"10","author":"G Finak","year":"2014","unstructured":"Finak, G. et al. OpenCyto: an open source infrastructure for scalable, robust, reproducible, and automated, end-to-end flow cytometry data analysis. PLoS Comput. Biol. 10, e1003806 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"216_CR77","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A 87, 636\u2013645 (2015).","journal-title":"Cytometry A"},{"key":"216_CR78","doi-asserted-by":"publisher","first-page":"748","DOI":"10.12688\/f1000research.11622.1","volume":"6","author":"M Nowicka","year":"2017","unstructured":"Nowicka, M. et al. CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets. Version 3; peer review: 2 approved. F1000Res. 6, 748 (2017).","journal-title":"F1000Res."},{"key":"216_CR79","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s42003-019-0415-5","volume":"2","author":"LM Weber","year":"2019","unstructured":"Weber, L. M., Nowicka, M., Soneson, C. & Robinson, M. D. diffcyt: differential discovery in high-dimensional cytometry via high-resolution clustering. Commun. Biol. 2, 183 (2019).","journal-title":"Commun. Biol."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00216-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00216-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00216-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T23:29:59Z","timestamp":1725319799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00216-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":79,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["216"],"URL":"https:\/\/doi.org\/10.1038\/s43018-021-00216-6","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"11 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}